FDA Approves Casgevy to Treat Beta-Thalassemia

Casgevy is the first CRISPR-based medicine to be approved for use in the United States.   Adobe Stock   WEDNESDAY, Jan. 17, 2024 (HealthDay News) — After approving Casgevy (exagamglogene autotemcel) in December to treat sickle cell disease, the U.S....